Shigeyuki Nishinaka
Directeur/Bestuurslid bij MYOVANT SCIENCES LTD.
Oorsprong van het eerstegraads netwerk van Shigeyuki Nishinaka
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 34 | |
| Subsidiary | Pharmaceuticals: Major | 15 | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA.
15
| Subsidiary | Pharmaceuticals: Major | 15 |
| Subsidiary | Biotechnology | 13 | |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries.
12
| Subsidiary | Pharmaceuticals: Major | 12 |
Sumitovant Biopharma, Inc.
 Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Meltin MMI KK
 Meltin MMI KK Medical SpecialtiesHealth Technology Meltin MMI KK develops bio-signal interface technologies. It offers biosignal processing and cable-driven ststems. The company was founded by Sumio Ito, Masahoro Kasuya and Tatsuya Seki and is headquartered in Tokyo, Japan.
3
| Holding Company | Medical Specialties | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Shigeyuki Nishinaka via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ALLERGAN, INC. | Pharmaceuticals: Major | Director of Finance/CFO Human Resources Officer | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Operating Officer Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
| RITE AID CORPORATION | Drugstore Chains | Director/Board Member Chief Administrative Officer | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member Chairman | |
Boston Biomedical, Inc.
 Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| AXSOME THERAPEUTICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Director/Board Member Corporate Officer/Principal Chief Executive Officer | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
Kyoto Pharmaceutical Industries Ltd.
 Kyoto Pharmaceutical Industries Ltd. Pharmaceuticals: MajorHealth Technology Kyoto Pharmaceutical Industries Ltd. engages in pharmaceutical products manufacturing. Its products include pharmaceuticals to regulate high-blood pressure, Ischemic heart disease treatment, digitalis formulation, and constipation remedies. The firm also develops and produces laxatives, anti-flatulence and anti-diarrheal medicines, and decongestants and cold medicines. The company was founded on September 5, 1946 and is headquartered in Kyoto, Japan. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Boston College | College/University | Doctorate Degree | |
| Brigham Young University | College/University | Undergraduate Degree | |
| ASTELLAS PHARMA INC. | Pharmaceuticals: Major | President | |
Astellas Pharma US, Inc.
 Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Pharmaceuticals: Major | President Corporate Officer/Principal Corporate Officer/Principal | |
| University of the Witwatersrand | College/University | Undergraduate Degree | |
| University of Tokyo | College/University | Graduate Degree Undergraduate Degree | |
| University of Science & Technology of China | College/University | Undergraduate Degree | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Pharmaceuticals: Major | President | |
Otic Pharma Ltd.
 Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director of Finance/CFO Chairman | |
| Daiamed LLC | Chief Tech/Sci/R&D Officer | ||
Nihon Medi-Physics Co., Ltd.
 Nihon Medi-Physics Co., Ltd. Pharmaceuticals: MajorHealth Technology Nihon Medi-Physics Co., Ltd. is a leading manufacturer of radiopharmaceuticals, based in Japan. The Japanese company is engaged in ensuring stable supply and research and development of new products. It is also working on research and development of "theranostics," a novel medical technology to provide optimal medical service to each patient, as well as on the dissemination of nuclear medicine in Asian countries by licensing its products. Nihon Medi-Physics Co. was founded in 1973, and the CEO is Nobuhiko Tamura. | Pharmaceuticals: Major | Chief Executive Officer | |
| ALLERGAN PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer Corporate Officer/Principal General Counsel | |
| USC Marshall School of Business | College/University | Masters Business Admin Undergraduate Degree | |
Astellas Pharma Global Development, Inc.
 Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
Amolyt Pharma SAS
 Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Primetals Technologies Ltd.
 Primetals Technologies Ltd. Information Technology ServicesTechnology Services Primetals Technologies Ltd. operates as a engineering and plant construction company. It manures of steel and iron products. The company was founded in January 2015 and is headquartered in London, the United Kingdom. | Information Technology Services | Director of Finance/CFO | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
Sunovion Pharmaceuticals Europe Ltd.
 Sunovion Pharmaceuticals Europe Ltd. Pharmaceuticals: MajorHealth Technology Sunovion Pharmaceuticals Europe Ltd. is a British European pharmaceutical company founded in 2013 that is dedicated to improving the lives of patients through the supply of essential medicines. The company is based in London, UK. The company commercializes and distributes a portfolio of specialty brands and hospital products in 40 countries worldwide, both directly and through strategic partnerships. The company's vision is to become a recognized partner of choice through their commercial excellence, patient focus, and presence across the globe. Sunovion Pharmaceuticals Europe aims to have a positive impact on society through their pioneering focus on their environment, social, and governance (ESG) goals. | Pharmaceuticals: Major | Chief Executive Officer | |
Myovant Sciences, Inc.
 Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Medical Specialties | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| ELEDON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chairman Compliance Officer Director/Board Member General Counsel | |
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Biotechnology | Director/Board Member Chairman | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Director/Board Member Director/Board Member Chief Executive Officer | |
Altavant Sciences, Inc.
 Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Dermavant Sciences Ltd.
 Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| IMMUNOVANT, INC. | Biotechnology | Director/Board Member Chairman |
Statistieken
Internationaal
| Verenigde Staten | 36 |
| Japan | 7 |
| Verenigd Koninkrijk | 5 |
| Zuid-Afrika | 2 |
| China | 2 |
Sectoraal
| Health Technology | 36 |
| Consumer Services | 8 |
| Commercial Services | 3 |
| Finance | 3 |
| Retail Trade | 2 |
Operationeel
| Director/Board Member | 221 |
| Corporate Officer/Principal | 110 |
| Independent Dir/Board Member | 58 |
| Chief Executive Officer | 41 |
| Chairman | 37 |
Sterkste connecties
| Insiders | |
|---|---|
| Pierre Legault | 45 |
| Myrtle Potter | 41 |
| Frank Torti | 35 |
| James Robinson | 23 |
| Keith Katkin | 16 |
| Adele Gulfo | 16 |
| Ajay Bansal | 15 |
| James Hindman | 14 |
| Mark Guinan | 11 |
| Terrie Curran | 10 |
| Nobuhiro Endo | 10 |
| Roger Xie | 10 |
| Sef P. Kurstjens | 10 |
| Nori Ebersole | 9 |
| Hiroshi Nomura | 8 |
- Beurs
- Insiders
- Shigeyuki Nishinaka
- Bedrijfsconnecties
